Institutional investors purchased a net $4.2 million shares of OPK during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 21.80% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST TRUST ADVISORS LP Bought 950.4 Thousand shares of OPKO Health Inc
HAREL-PIA MUTUAL FUNDS LTD. Bought 902.2 Thousand shares of OPKO Health Inc
SSGA FUNDS MANAGEMENT, INC. Bought 773.9 Thousand shares of OPKO Health Inc